Position in SHPH
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$3,849
-$17,655 QoQ
Shares Held
567
-52.6% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SHPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,368 across 82 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in SHPH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,849 | 5,670 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $21,504 | 11,947 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $28 | 8 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,676 | 3,367 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $28,164 | 32,787 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $455 | 1,121 | Shares | Sole | 2024-05-13 | |
| 2022-12-31 | $950 | 485 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $155,830 | 33,950 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||